Currently holds positions in Adamas Pharmaceuticals Inc and Chimerix Inc
Position | Company | Period |
---|---|---|
Director | Adamas Pharmaceuticals Inc | March 1, 2014 - |
Independent Chairman of the Board | Chimerix Inc | June 20, 2018 - |
Independent Director | Chimerix Inc | Jan. 1, 2005 - June 1, 2018 |
Independent Director | Evofem Biosciences Inc | July 1, 2014 - Jan. 17, 2018 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2023-05-11 | 2023-05-10 |
Chimerix Inc
(CMRX)
|
B Purchase |
18,000
+33.3%
1.1119,980 USD |
18,000 +33.3% | 1.11 | 19,980 USD | |
2022-05-17 | 2022-05-17 |
Chimerix Inc
(CMRX)
|
B Purchase |
10,000
+22.7%
1.6116,100 USD |
10,000 +22.7% | 1.61 | 16,100 USD | |
2021-06-08 | 2021-06-07 |
Adamas Pharmaceuticals Inc
(ADMS)
|
PS Planned sale |
2,000
-20.0%
5.1710,340 USD |
2,000 -20.0% | 5.17 | 10,340 USD | |
2020-09-14 | 2020-09-11 |
ADMA Biologics Inc
(ADMA)
|
B Purchase |
2,200
+110.0%
2.295,038 USD |
2,200 +110.0% | 2.29 | 5,038 USD | |
2020-08-14 | 2020-08-13 |
ADMA Biologics Inc
(ADMA)
|
B Purchase |
2,000
+inf%
2.885,760 USD |
2,000 +inf% | 2.88 | 5,760 USD | |
2020-08-11 | 2020-08-10 |
Chimerix Inc
(CMRX)
|
PS Planned sale |
1,584
-100.0%
3.255,148 USD |
1,584 -100.0% | 3.25 | 5,148 USD | |
2020-08-10 | 2020-08-07 |
Chimerix Inc
(CMRX)
|
PS Planned sale |
2,500
-100.0%
3.258,125 USD |
2,500 -100.0% | 3.25 | 8,125 USD | |
2020-08-10 | 2020-08-06 |
Chimerix Inc
(CMRX)
|
PS Planned sale |
2,500
-100.0%
3.298,224 USD |
2,500 -100.0% | 3.29 | 8,224 USD | |
2020-08-06 | 2020-08-05 |
Chimerix Inc
(CMRX)
|
PS Planned sale |
2,500
-100.0%
3.278,187 USD |
2,500 -100.0% | 3.27 | 8,187 USD | |
2020-08-06 | 2020-08-04 |
Chimerix Inc
(CMRX)
|
PS Planned sale |
5,000
-100.0%
3.2516,250 USD |
5,000 -100.0% | 3.25 | 16,250 USD | |
2019-05-29 | 2019-05-28 |
Chimerix Inc
(CMRX)
|
B Purchase |
18,000
+94.7%
3.6064,800 USD |
18,000 +94.7% | 3.60 | 64,800 USD |